EcoR1 Capital LLC 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 1:36 pm Sale | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital LLC | 0 0.000% | -2,759,505![]() (Position Closed) | Filing |
2022-02-14 3:03 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital LLC | 2,759,505 5.900% | 655,555![]() (+31.16%) | Filing |
2021-02-16 12:10 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital LLC | 2,103,950 5.600% | 2,103,950![]() (New Position) | Filing |